Evidence map›Paper›PMID 39156673›Full record

ArticleJournal of hepatocellular carcinoma2024

Genetic Variants in p53 Pathway Genes Affect Survival of Patients with HBV-Related Hepatocellular Carcinoma.

Liming Qin, Moqin Qiu, Jingmei Tang, Shuyan Liu, Qiuling Lin, Qiongguang Huang, Xiaoxia Wei, Qiuping Wen, Peiqin Chen, Zihan Zhou and 9 more

Abstract read
In one paragraph

Article in Journal of hepatocellular carcinoma, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Association ofAnnals of medicine · 2025
    Article
  2. Annals of medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Liming Qin *Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Moqin Qiu *Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Jingmei TangSchool of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
Shuyan LiuKey Laboratory of Biological Molecular Medicine Research, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, People's Republic of China.
Qiuling LinDepartment of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Qiongguang HuangSchool of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
Xiaoxia WeiDepartment of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Qiuping WenDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Peiqin ChenEditorial Department of Chinese Journal of Oncology Prevention and Treatment, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Zihan ZhouDepartment of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.ORCID 0000-0003-1444-4713
Ji CaoDepartment of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Xiumei LiangDepartment of Disease Process Management, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Qian GuoLiuzhou Worker's Hospital, Liuzhou, People's Republic of China.
Cunli NongLiuzhou Worker's Hospital, Liuzhou, People's Republic of China.
Yizhen GongDepartment of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.ORCID 0000-0002-6236-8340
Yuying WeiDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Yanji JiangDepartment of Scientific Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Hongping YuDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.
Yingchun LiuDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Methods: We evaluated the associations between 4698 SNPs in 70 genes of the p53 pathway and overall survival (OS) of 866 patients in additive genetic models by using Cox proportional hazards regression analysis. Stepwise multivariable Cox regression analysis was conducted to determine the independent effects of identified SNPs in single-locus analyses. The expression of quantitative trait loci (eQTL) was also analyzed using data from GTEx and 1000 Genomes Project, and functional prediction of SNPs was performed by using RegulomeDB v2.2, 3DSNP v2.0, HaploReg v4.2 and VannoPortal. Results: We found that two novel SNPs of Conclusion: We identified two observed survival-associated SNPs in

Indexed as

genetic variantshepatitis B virushepatocellular carcinomap53 signaling pathwaysurvival

Identifiers

PMID39156673
PMCPMC11328861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.